Kestra Investment Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1962449
AUSTIN, TX
Position in REGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$410,912
+$410,387 QoQ
Shares Held
659
+65800.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#855
of 1,322 holders
Holding Since
Jun 2024
6 quarters on record
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kestra Investment Management, LLC holds $5,070,571 across 6 Biotechnology names. REGN ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
31,530 | $1,715,547 | |
| 2 | INCY |
Incyte Corp
|
12,148 | $1,377,097 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,618 | $788,096 | |
| 4 | RPRX |
Royalty Pharma plc
|
7,788 | $436,673 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
659 | $410,912 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
689 | $342,246 |
All Filings in REGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $410,912 | 659 | Shares | Sole | 2026-08-05 | |
| 2025-06-30 | $525 | 1 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $634 | 1 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $897,535 | 1,260 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $647,563 | 616 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $437,228 | 416 | Shares | Sole | 2024-08-28 | |
| No filing history on record for this holder in this stock. | ||||||